Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Statins affect human glioblastoma and other cancers through TGF-β inhibition.

Xiao A, Brenneman B, Floyd D, Comeau L, Spurio K, Olmez I, Lee J, Nakano I, Godlewski J, Bronisz A, Kagaya N, Shin-Ya K, Purow B.

Oncotarget. 2019 Mar 1;10(18):1716-1728. doi: 10.18632/oncotarget.26733. eCollection 2019 Mar 1.

2.

MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy.

Ogawa D, Ansari K, Nowicki MO, Salińska E, Bronisz A, Godlewski J.

Noncoding RNA. 2019 Mar 15;5(1). pii: E25. doi: 10.3390/ncrna5010025.

3.

The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.

Bhaskaran V, Nowicki MO, Idriss M, Jimenez MA, Lugli G, Hayes JL, Mahmoud AB, Zane RE, Passaro C, Ligon KL, Haas-Kogan D, Bronisz A, Godlewski J, Lawler SE, Chiocca EA, Peruzzi P.

Nat Commun. 2019 Jan 25;10(1):442. doi: 10.1038/s41467-019-08390-z.

4.

A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine.

Jun HJ, Appleman VA, Wu HJ, Rose CM, Pineda JJ, Yeo AT, Delcuze B, Lee C, Gyuris A, Zhu H, Woolfenden S, Bronisz A, Nakano I, Chiocca EA, Bronson RT, Ligon KL, Sarkaria JN, Gygi SP, Michor F, Mitchison TJ, Charest A.

Nat Commun. 2018 Aug 6;9(1):3116. doi: 10.1038/s41467-018-05036-4.

5.

The activation of group II metabotropic glutamate receptors protects neonatal rat brains from oxidative stress injury after hypoxia-ischemia.

Bratek E, Ziembowicz A, Bronisz A, Salinska E.

PLoS One. 2018 Jul 25;13(7):e0200933. doi: 10.1371/journal.pone.0200933. eCollection 2018.

6.

Pregnancy Ketonemia and Development of the Fetal Central Nervous System.

Bronisz A, Ozorowski M, Hagner-Derengowska M.

Int J Endocrinol. 2018 Jun 4;2018:1242901. doi: 10.1155/2018/1242901. eCollection 2018. Review.

7.

Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.

Olmez I, Zhang Y, Manigat L, Benamar M, Brenneman B, Nakano I, Godlewski J, Bronisz A, Lee J, Abbas T, Abounader R, Purow B.

Cancer Res. 2018 Aug 1;78(15):4360-4369. doi: 10.1158/0008-5472.CAN-17-3124. Epub 2018 May 29.

8.

Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.

Ricklefs FL, Alayo Q, Krenzlin H, Mahmoud AB, Speranza MC, Nakashima H, Hayes JL, Lee K, Balaj L, Passaro C, Rooj AK, Krasemann S, Carter BS, Chen CC, Steed T, Treiber J, Rodig S, Yang K, Nakano I, Lee H, Weissleder R, Breakefield XO, Godlewski J, Westphal M, Lamszus K, Freeman GJ, Bronisz A, Lawler SE, Chiocca EA.

Sci Adv. 2018 Mar 7;4(3):eaar2766. doi: 10.1126/sciadv.aar2766. eCollection 2018 Mar.

9.

Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.

Olmez I, Love S, Xiao A, Manigat L, Randolph P, McKenna BD, Neal BP, Boroda S, Li M, Brenneman B, Abounader R, Floyd D, Lee J, Nakano I, Godlewski J, Bronisz A, Sulman EP, Mayo M, Gioeli D, Weber M, Harris TE, Purow B.

Neuro Oncol. 2018 Jan 22;20(2):192-202. doi: 10.1093/neuonc/nox119.

10.

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma.

Speranza MC, Passaro C, Ricklefs F, Kasai K, Klein SR, Nakashima H, Kaufmann JK, Ahmed AK, Nowicki MO, Obi P, Bronisz A, Aguilar-Cordova E, Aguilar LK, Guzik BW, Breakefield X, Weissleder R, Freeman GJ, Reardon DA, Wen PY, Chiocca EA, Lawler SE.

Neuro Oncol. 2018 Jan 22;20(2):225-235. doi: 10.1093/neuonc/nox139.

11.

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

Li M, Xiao A, Floyd D, Olmez I, Lee J, Godlewski J, Bronisz A, Bhat KPL, Sulman EP, Nakano I, Purow B.

Oncotarget. 2017 Jul 21;8(33):55319-55331. doi: 10.18632/oncotarget.19429. eCollection 2017 Aug 15.

12.

Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.

Olmez I, Brenneman B, Xiao A, Serbulea V, Benamar M, Zhang Y, Manigat L, Abbas T, Lee J, Nakano I, Godlewski J, Bronisz A, Abounader R, Leitinger N, Purow B.

Clin Cancer Res. 2017 Nov 15;23(22):6958-6968. doi: 10.1158/1078-0432.CCR-17-0803. Epub 2017 Aug 16.

13.

MicroRNA-Mediated Dynamic Bidirectional Shift between the Subclasses of Glioblastoma Stem-like Cells.

Rooj AK, Ricklefs F, Mineo M, Nakano I, Chiocca EA, Bronisz A, Godlewski J.

Cell Rep. 2017 Jun 6;19(10):2026-2032. doi: 10.1016/j.celrep.2017.05.040.

14.

MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer.

Godlewski J, Ferrer-Luna R, Rooj AK, Mineo M, Ricklefs F, Takeda YS, Nowicki MO, Salińska E, Nakano I, Lee H, Weissleder R, Beroukhim R, Chiocca EA, Bronisz A.

Stem Cell Reports. 2017 Jun 6;8(6):1497-1505. doi: 10.1016/j.stemcr.2017.04.024. Epub 2017 May 18.

15.

The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches.

Mineo M, Ricklefs F, Rooj AK, Lyons SM, Ivanov P, Ansari KI, Nakano I, Chiocca EA, Godlewski J, Bronisz A.

Cell Rep. 2016 Jun 14;15(11):2500-9. doi: 10.1016/j.celrep.2016.05.018. Epub 2016 Jun 2.

16.

Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity.

Ricklefs F, Mineo M, Rooj AK, Nakano I, Charest A, Weissleder R, Breakefield XO, Chiocca EA, Godlewski J, Bronisz A.

Cancer Res. 2016 May 15;76(10):2876-81. doi: 10.1158/0008-5472.CAN-15-3432. Epub 2016 Mar 24.

17.

Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.

Bronisz A, Godlewski J, Chiocca EA.

Cell Mol Neurobiol. 2016 Apr;36(3):361-76. doi: 10.1007/s10571-015-0293-4. Epub 2016 Mar 17. Review.

18.

The role of octamer binding transcription factors in glioblastoma multiforme.

Rooj AK, Bronisz A, Godlewski J.

Biochim Biophys Acta. 2016 Jun;1859(6):805-11. doi: 10.1016/j.bbagrm.2016.03.003. Epub 2016 Mar 8. Review.

19.

The influence of a ten-week Nordic walking training-rehabilitation program on the level of lipids in blood in overweight and obese postmenopausal women.

Hagner-Derengowska M, Kałużny K, Hagner W, Kochański B, Plaskiewicz A, Borkowska A, Bronisz A, Budzyński J.

J Phys Ther Sci. 2015 Oct;27(10):3039-44. doi: 10.1589/jpts.27.3039. Epub 2015 Oct 30.

20.

The effect of a 10-week Nordic walking training program on the level of GH and LH in elderly women.

Hagner-Derengowska M, Kałużny K, Hagner W, Plaskiewicz A, Bronisz A, Borkowska A, Budzyński J.

Climacteric. 2015;18(6):835-40. doi: 10.3109/13697137.2015.1058354. Epub 2015 Sep 25.

PMID:
26406397
21.

Response to energy depletion: miR-451/AMPK loop.

Bronisz A, Chiocca EA, Godlewski J.

Oncotarget. 2015 Jul 20;6(20):17851-2. No abstract available.

22.

Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant.

Carey HA, Bronisz A, Cabrera J, Hildreth BE 3rd, Cuitiño M, Fu Q, Ahmad A, Toribio RE, Ostrowski MC, Sharma SM.

J Cell Physiol. 2016 Mar;231(3):630-40. doi: 10.1002/jcp.25108.

23.

A cross-talk network that facilitates tumor virotherapy.

Bronisz A, Chiocca EA.

Nat Med. 2015 May;21(5):426-7. doi: 10.1038/nm.3857. No abstract available.

PMID:
25951527
24.

Glucose-based regulation of miR-451/AMPK signaling depends on the OCT1 transcription factor.

Ansari KI, Ogawa D, Rooj AK, Lawler SE, Krichevsky AM, Johnson MD, Chiocca EA, Bronisz A, Godlewski J.

Cell Rep. 2015 May 12;11(6):902-909. doi: 10.1016/j.celrep.2015.04.016. Epub 2015 Apr 30.

25.

Belonging to a network--microRNAs, extracellular vesicles, and the glioblastoma microenvironment.

Godlewski J, Krichevsky AM, Johnson MD, Chiocca EA, Bronisz A.

Neuro Oncol. 2015 May;17(5):652-62. doi: 10.1093/neuonc/nou292. Epub 2014 Oct 9. Review.

26.

MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.

Kabbout M, Dakhlallah D, Sharma S, Bronisz A, Srinivasan R, Piper M, Marsh CB, Ostrowski MC.

PLoS One. 2014 Jun 26;9(6):e100693. doi: 10.1371/journal.pone.0100693. eCollection 2014.

27.

Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.

Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, Honka M, Janez A, Krnic M, Lalic N, Martinka E, Rahelic D, Roman G, Tankova T, Várkonyi T, Wolnik B, Zherdova N.

Diabetes Technol Ther. 2014 Jul;16(7):460-75. doi: 10.1089/dia.2013.0302. Epub 2014 Apr 9. Review.

28.

Lactic acidosis occurrence during exercises in the smoke chamber in a 53-year-old firefighter with no significant medical history.

Bronisz A, Spychalska M, Szafrańska M.

Int J Occup Med Environ Health. 2014 Apr;27(2):335-9. doi: 10.2478/s13382-014-0263-y. Epub 2014 Apr 1.

29.

Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.

Bronisz A, Wang Y, Nowicki MO, Peruzzi P, Ansari K, Ogawa D, Balaj L, De Rienzo G, Mineo M, Nakano I, Ostrowski MC, Hochberg F, Weissleder R, Lawler SE, Chiocca EA, Godlewski J.

Cancer Res. 2014 Feb 1;74(3):738-750. doi: 10.1158/0008-5472.CAN-13-2650. Epub 2013 Dec 5.

30.

The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF).

Bronisz A, Carey HA, Godlewski J, Sif S, Ostrowski MC, Sharma SM.

J Biol Chem. 2014 Jan 3;289(1):326-34. doi: 10.1074/jbc.M113.493874. Epub 2013 Nov 20.

31.

MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.

Peruzzi P, Bronisz A, Nowicki MO, Wang Y, Ogawa D, Price R, Nakano I, Kwon CH, Hayes J, Lawler SE, Ostrowski MC, Chiocca EA, Godlewski J.

Neuro Oncol. 2013 Sep;15(9):1212-24. doi: 10.1093/neuonc/not055. Epub 2013 Jun 3.

32.

Infection caused by Aeromonas sobria, complicated by lower extremity paraplegia and the cauda equine syndrome in a patient with well-controlled type 2 diabetes.

Szafrańska M, Szafrański J, Bronisz A, Junik R.

Arch Med Sci. 2013 Apr 20;9(2):384-5. doi: 10.5114/aoms.2012.30832. Epub 2012 Oct 8. No abstract available.

33.

Pathomechanisms of the development of obesity in some endocrinopathies - an overview.

Pujanek M, Bronisz A, Małecki P, Junik R.

Endokrynol Pol. 2013;64(2):150-5. Review.

34.

SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility.

He H, Bronisz A, Liyanarachchi S, Nagy R, Li W, Huang Y, Akagi K, Saji M, Kula D, Wojcicka A, Sebastian N, Wen B, Puch Z, Kalemba M, Stachlewska E, Czetwertynska M, Dlugosinska J, Dymecka K, Ploski R, Krawczyk M, Morrison PJ, Ringel MD, Kloos RT, Jazdzewski K, Symer DE, Vieland VJ, Ostrowski M, Jarząb B, de la Chapelle A.

J Clin Endocrinol Metab. 2013 May;98(5):E973-80. doi: 10.1210/jc.2012-3823. Epub 2013 Mar 28.

35.

MEK-1 activates C-Raf through a Ras-independent mechanism.

Leicht DT, Balan V, Zhu J, Kaplun A, Bronisz A, Rana A, Tzivion G.

Biochim Biophys Acta. 2013 May;1833(5):976-86. doi: 10.1016/j.bbamcr.2013.01.015. Epub 2013 Jan 27.

36.

Stress hyperglycaemia in patients with first myocardial infarction.

Bronisz A, Kozinski M, Magielski P, Fabiszak T, Bronisz M, Swiatkiewicz I, Sukiennik A, Beszczynska B, Junik R, Kubica J.

Int J Clin Pract. 2012 Jun;66(6):592-601. doi: 10.1111/j.1742-1241.2012.02917.x.

PMID:
22607511
37.

Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.

Świątkiewicz I, Magielski P, Woźnicki M, Gierach J, Jabłoński M, Fabiszak T, Koziński M, Sukiennik A, Bronisz A, Kubica J.

Kardiol Pol. 2012;70(4):329-40.

PMID:
22528703
38.

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.

Bronisz A, Godlewski J, Wallace JA, Merchant AS, Nowicki MO, Mathsyaraja H, Srinivasan R, Trimboli AJ, Martin CK, Li F, Yu L, Fernandez SA, Pécot T, Rosol TJ, Cory S, Hallett M, Park M, Piper MG, Marsh CB, Yee LD, Jimenez RE, Nuovo G, Lawler SE, Chiocca EA, Leone G, Ostrowski MC.

Nat Cell Biol. 2011 Dec 18;14(2):159-67. doi: 10.1038/ncb2396.

39.

Value of oral glucose tolerance test in the acute phase of myocardial infarction.

Bronisz A, Kozinski M, Magielski P, Fabiszak T, Gierach J, Swiatkiewicz I, Sukiennik A, Kubica A, Bronisz M, Grabczewska Z, Sinkiewicz A, Junik R, Kubica J.

Cardiovasc Diabetol. 2011 Mar 11;10:21. doi: 10.1186/1475-2840-10-21.

40.

microRNA-451: A conditional switch controlling glioma cell proliferation and migration.

Godlewski J, Bronisz A, Nowicki MO, Chiocca EA, Lawler S.

Cell Cycle. 2010 Jul 15;9(14):2742-8. Epub 2010 Jul 30.

PMID:
20647762
41.

An evaluation of visfatin levels in obese subjects.

Kamińska A, Kopczyńska E, Bronisz A, Zmudzińska M, Bieliński M, Borkowska A, Tyrakowski T, Junik R.

Endokrynol Pol. 2010 Mar-Apr;61(2):169-73.

42.

MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, Van Brocklyn J, Ostrowski MC, Chiocca EA, Lawler SE.

Mol Cell. 2010 Mar 12;37(5):620-32. doi: 10.1016/j.molcel.2010.02.018.

43.

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S.

Cancer Res. 2008 Nov 15;68(22):9125-30. doi: 10.1158/0008-5472.CAN-08-2629.

44.

Spontaneous baroreflex sensitivity in subjects with type 1 diabetes with and without cardiovascular autonomic neuropathy.

Kamińska A, Tafil-Klawe M, Smietanowski M, Bronisz A, Ruprecht Z, Klawe J, Junik R.

Endokrynol Pol. 2008 Sep-Oct;59(5):398-402.

PMID:
18979450
45.

Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.

Bronisz A, Rosc D, Bronisz M, Szymanski W, Junik R.

Med Sci Monit. 2008 Nov;14(11):CR574-9.

PMID:
18971874
46.

The Ewing sarcoma protein (EWS) binds directly to the proximal elements of the macrophage-specific promoter of the CSF-1 receptor (csf1r) gene.

Hume DA, Sasmono T, Himes SR, Sharma SM, Bronisz A, Constantin M, Ostrowski MC, Ross IL.

J Immunol. 2008 May 15;180(10):6733-42.

47.

Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.

Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U, Ostrowski MC.

Mol Cell Biol. 2007 Jun;27(11):4018-27. Epub 2007 Apr 2.

48.

MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.

Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S, Ostrowski MC.

J Biol Chem. 2007 May 25;282(21):15921-9. Epub 2007 Apr 2.

49.

Genetics and genomics of osteoclast differentiation: integrating cell signaling pathways and gene networks.

Sharma SM, Hu R, Bronisz A, Meadows N, Lusby T, Fletcher B, Hume DA, Cassady AI, Ostrowski MC.

Crit Rev Eukaryot Gene Expr. 2006;16(3):253-77. Review.

PMID:
17073554
50.

Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors.

Bronisz A, Sharma SM, Hu R, Godlewski J, Tzivion G, Mansky KC, Ostrowski MC.

Mol Biol Cell. 2006 Sep;17(9):3897-906. Epub 2006 Jul 5.

Supplemental Content

Loading ...
Support Center